$18.90
0.26% day before yesterday
Nasdaq, Dec 24, 07:15 pm CET
ISIN
US24906P1093
Symbol
XRAY

Dentsply Sirona Stock price

$18.90
-0.62 3.18% 1M
-6.11 24.43% 6M
-16.69 46.90% YTD
-16.32 46.34% 1Y
-37.05 66.22% 3Y
-38.31 66.96% 5Y
-34.86 64.84% 10Y
Nasdaq, Closing price Wed, Dec 25 2024
+0.00 0.00%
ISIN
US24906P1093
Symbol
XRAY
Sector

Key metrics

Market capitalization $3.76b
Enterprise Value $5.78b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 15.84
EV/Sales (TTM) EV/Sales 1.48
P/S ratio (TTM) P/S ratio 0.96
P/B ratio (TTM) P/B ratio 1.51
Dividend yield 3.39%
Last dividend (FY24) $0.64
Revenue growth (TTM) Revenue growth -0.91%
Revenue (TTM) Revenue $3.90b
EBIT (operating result TTM) EBIT $264.00m
Free Cash Flow (TTM) Free Cash Flow $365.00m
Cash position $296.00m
EPS (TTM) EPS $-2.07
P/E forward negative
P/S forward 0.99
EV/Sales forward 1.52
Short interest 4.93%
Show more

Is Dentsply Sirona a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,885 stocks worldwide.

Dentsply Sirona Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Dentsply Sirona forecast:

8x Buy
50%
8x Hold
50%

Analyst Opinions

16 Analysts have issued a Dentsply Sirona forecast:

Buy
50%
Hold
50%

Financial data from Dentsply Sirona

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3,900 3,900
1% 1%
100%
- Direct Costs 1,864 1,864
1% 1%
48%
2,036 2,036
3% 3%
52%
- Selling and Administrative Expenses 1,260 1,260
1% 1%
32%
- Research and Development Expense 166 166
10% 10%
4%
610 610
5% 5%
16%
- Depreciation and Amortization 346 346
3% 3%
9%
EBIT (Operating Income) EBIT 264 264
14% 14%
7%
Net Profit -413 -413
93% 93%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Dentsply Sirona directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dentsply Sirona Stock News

Neutral
PRNewsWire
about 7 hours ago
NEW YORK , Dec. 25, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between February 28, 2022 and November 6, 2024, both dates inclusive (the "Class Period"), of the important January 27, 2025 lead plaintiff deadline. So what: If you purchased Dentsply Sirona common stock during the Class Peri...
Neutral
PRNewsWire
2 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Dentsply between February 28, 2022 and November 6 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4...
Neutral
GlobeNewsWire
3 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
More Dentsply Sirona News

Company Profile

Dentsply Sirona, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in Charlotte, NC.

Head office United States
CEO Simon Campion
Employees 15,000
Founded 1899
Website www.dentsplysirona.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today